TokenomicsTransparency

$BIO /USDT

Price: ~$0.0894 Change: +54.14%

---

News & Fundamentals

Bio Protocol is embracing its V2 phase, introducing linear vesting for 4.23% of BIO tokens from Nov 2025 to May 2026 to reduce volatility. The update also adds new DeSci features like BioAgents, IP-Tokens, and dCLINIC v1.0. A BIO‑USD trading pair is launching, marking growing adoption and institutional interest.

---

Technicals (M15, H1, H4)

Immediate momentum strong in short-term frames; however, data for these micro-charts is limited. On longer-term daily charts, price action suggests a steep rally but lacks defined patterns—indicators show overbought conditions, warranting cautious continuation.

---

Smart Money / Whale Activity – Manipulation Test

Token unlocks are clearly documented: ~56.5% of total supply is unlocked, with major allocations like Core Contributors gradually vesting through 2030; critical team tokens were rescheduled from a cliff unlock to linear release. This structured approach significantly reduces manipulation risk.

---

Sentiment

Neutral–Slightly Bullish
Momentum is lifted by institutional listings and improved tokenomics. Balanced vesting and utility upgrades support a constructive outlook.

---

Trade Ideas

• Long bias
  Entry: $0.085–$0.088
  SL: $0.082
  TP1: $0.095, TP2: $0.105

• Momentum long (if breakout above $0.095)
  Entry: > $0.095
  SL: $0.092
  TP: $0.110–$0.115

• Short bias (if rejection at $0.095–$0.100)
  Entry: $0.098
  SL: $0.102
  TP: $0.088, TP2: $0.082

---

#BIO_USDT #DeSciUpgrade #TokenomicsTransparency